Production of the vaccine against coronavirus in Russia is planned to begin by the end of the summer. The Director of the research Institute of epidemiology and Microbiology them. N. F. Gamalei of the Ministry of health of the Russian Federation Alexander Ginzburg said in an interview with the RIA Novosti news Agency.
“We have such terms put, on the assumption that all one has to do in the face of the pandemic by the end of summer, so we tried to come to production. Unfortunately, the production immediately would not allow a large number of our population to immunize, but are now taken by healthcare administrators unprecedented efforts and actions to when the vaccine will be registered as quickly as possible to go to scale it,” – said Alexander Ginzburg.
the day Before, 22 may, the health Ministry announced that it will reduce the time to market of the drug from COVID-19 “Favipiravir”, which is undergoing clinical trials. As explained in Department, this drug is not yet registered, and only patients with COVID-19 who participate in clinical trials.
As earlier reported “RG” in Russia, developed nine prototypes of the vaccines included in the list of promising developments, the world health organization (who). Six of them are developed by state research center “Vector” of Rospotrebnadzor, two company “Biocard”, one of the Saint-Petersburg research Institute of vaccines and sera.
